Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuta Tomida

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Plos One|April 16, 2015
Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinibHiroshi Mizuuchi, Kenichi Suda, Katsuaki Sato, et al.
Cancer Medicine|April 18, 2025
Genomic Differences and Distinct TP53 Mutation Site-Linked Chemosensitivity in Early- and Late-Onset Gastric CancerTomohiro Kamio, Yoshiyasu Kono, Kensuke Hirosuna, et al.
Plos One|August 4, 2012
An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strainsAndrew McDowell, Emma Barnard, István Nagy, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 13, 2024
Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitisMinori Sasakura, Hitoshi Urakami, Kota Tachibana, et al.
Scientific Reports|September 25, 2015
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancerKenichi Suda, Isao Murakami, Kazuko Sakai, et al.
Oncogene|January 20, 2018
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancersHiroshi Kotani, Yuta Adachi, Hidenori Kitai, et al.
Cancer Cell|March 24, 2012
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinomaTomoya Yamaguchi, Kiyoshi Yanagisawa, Ryoji Sugiyama, et al.
Cancer Science|October 23, 2025
Comparative Analysis of a Dual DNA-RNA Panel and a DNA-Only Panel for Sarcoma: Real-World Data From a Nationwide Genomic DatabaseEiji Nakata, Kiichiro Ninomiya, Tatsunori Osone, et al.
Acta Medica Okayama|September 19, 2022
Liquid Biopsy Revealed HBOC Pedigree and Led to Medical Management Among the RelativesChikako Ogawa, Akira Hirasawa, Reimi Sogawa, et al.
Cancer Discovery|May 8, 2016
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung CancerHidenori Kitai, Hiromichi Ebi, Shuta Tomida, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Plos One|April 16, 2015
Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinibHiroshi Mizuuchi, Kenichi Suda, Katsuaki Sato, et al.
Cancer Medicine|April 18, 2025
Genomic Differences and Distinct TP53 Mutation Site-Linked Chemosensitivity in Early- and Late-Onset Gastric CancerTomohiro Kamio, Yoshiyasu Kono, Kensuke Hirosuna, et al.
Plos One|August 4, 2012
An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strainsAndrew McDowell, Emma Barnard, István Nagy, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 13, 2024
Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitisMinori Sasakura, Hitoshi Urakami, Kota Tachibana, et al.
Scientific Reports|September 25, 2015
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancerKenichi Suda, Isao Murakami, Kazuko Sakai, et al.
Oncogene|January 20, 2018
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancersHiroshi Kotani, Yuta Adachi, Hidenori Kitai, et al.
Cancer Cell|March 24, 2012
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinomaTomoya Yamaguchi, Kiyoshi Yanagisawa, Ryoji Sugiyama, et al.
Cancer Science|October 23, 2025
Comparative Analysis of a Dual DNA-RNA Panel and a DNA-Only Panel for Sarcoma: Real-World Data From a Nationwide Genomic DatabaseEiji Nakata, Kiichiro Ninomiya, Tatsunori Osone, et al.
Acta Medica Okayama|September 19, 2022
Liquid Biopsy Revealed HBOC Pedigree and Led to Medical Management Among the RelativesChikako Ogawa, Akira Hirasawa, Reimi Sogawa, et al.
Cancer Discovery|May 8, 2016
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung CancerHidenori Kitai, Hiromichi Ebi, Shuta Tomida, et al.
Pageof 17